Browse Studies — Arctuva

Observational

Checkpoint Inhibitor Associated Diabetes Mellitus: Early Recognition and Treatment (CERT) Project: A Pilot Study

To find out if taking a drug called infliximab (the "study drug") is safe and effective in reversing insulin dependence in CIADM.

Checkpoint InhibitorPilot StudyDiabetes Melletus

Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT07257068

Global Cardio Oncology Registry

G-COR is the first Global Prospective Cardio-Oncology Registry. It is a multinational, multicenter prospective observational cohort registry, with the goal of …

Breast CancerHematologic MalignancyImmune Checkpoint Inhibitor-Related Myocarditis+2 more

Estimated

~$10 – $750

The Cleveland ClinicNCT05598879

Phase 2

Early Concomitant Vedolizumab as First-Line for Immune-Related Colitis Therapy Trial

The goal of this clinical trial is to compare the effectiveness and safety of Vedolizumab with a short course of steroids compared to standard course of steroi…

Immune Checkpoint Inhibitor-Related Colitis

Estimated

~$10 – $7,500

Shilpa Grover, MD, MPHNCT06841705

A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy

To understand the severity and nature of participants experiences during irAEs following immune checkpoint inhibitor immunotherapy.

ArthritisPolymyalgia RheumaticaImmune Checkpoint Inhibitors

Estimated

~$10 – $750

M.D. Anderson Cancer CenterNCT06647134